Southampton Hospital hosted a ground-breaking ceremony on August 12, 2013 to celebrate the beginning of its new Audrey and Martin Gruss Heart and Stroke Center and to honor the Gruss’ extraordinary gift of $5 million to the new facility at the Hospital.  When completed, the Center will provide stroke treatment and carotid stents as needed and will consolidate a broad spectrum of new and sophisticated diagnostic and treatment capabilities with existing cardiovascular programs and services. 

Cardiologists at the University of Rochester Medical Center are launching a new study in an effort to improve the treatment of a very common form of heart disease in the Asian population.

The Texas Council on Cardiovascular Disease (CVD) and Stroke, in conjunction with the CVD & Stroke Program of the Texas Department of State Health Services, will present Healthy Lubbock with the Department of State Health Services 2013 Cardiovascular Health Promotions Award.

The Wall Street Journal recently featured two pediatric approaches to treat children with congenital heart defects that cause them to be born with only one ventricle. The article and video are below.

Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced that its subsidiary Hotspur Technologies, Inc., which Teleflex acquired in June 2012, received FDA 510(k) clearance to market the company’s ARROW® GPSCath® Balloon Dilatation Catheters in Higher Rated Burst Pressure (RBP) and 80 cm lengths. These novel products enable multiple vascular procedures to be performed with one dual-function catheter, potentially reducing procedure time and expense for both patients and medical professionals.

eCardio Diagnostics, a leader in remote arrhythmia monitoring services, has promoted John H. Untereker to President, effective immediately. He will remain COO.

The Accreditation for Cardiovascular Excellence (ACE) announced this week that updated standards for cardiac intervention procedures have been published and are now available for download on the ACE website. ACE updated its Cath/PCI standards to align with the recently published clinical competency document for PCI which includes information on physician training, clinical competency criteria and the updated expert consensus document published in 2012.

Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Rhythmia™ Mapping System, a next-generation 3D mapping and navigation solution for use in cardiac catheter ablations and other electrophysiology (EP) procedures to diagnose or treat a variety of conditions in which the heart beats abnormally.